Timing of Human Insulin-Like Growth Factor-1 Gene Transfer in Reinnervating Laryngeal Muscle

Hideki Nakagawa, Akihiro Shiotani, Bert W. O'Malley, Michael E. Coleman, Paul W. Flint

Research output: Contribution to journalArticle

Abstract

Objectives/Hypothesis: The authors have designed a rat laryngeal paralysis model to study gene transfer strategies using a muscle-specific expression system to enhance local delivery of human insulin-like growth factor-1 (hIGF-1). In preliminary studies, a nonviral vector containing the α-actin promoter and human hIGF-1 sequence produced both neurotrophic and myotrophic effects 1 month after single injection of plasmid formulation into paralyzed rat thyroarytenoid muscle in vivo. Based on these findings, it is hypothesized that the effects of hIGF-1 will enhance the results of laryngeal muscle innervation procedures. The timing of gene delivery relative to nerve repair is likely to be important, to optimize the results. Study Design: Prospective analysis. Methods: The effects of nonviral gene transfer for the delivery of hIGF-1 were evaluated in rats treated immediately following recurrent laryngeal nerve transection and repair and in rats receiving a delayed treatment schedule, 30 days after nerve transection and repair. Gene transfer efficiency was determined using polymerase chain reaction and reverse transcriptase-polymerase chain reaction techniques. Muscle fiber diameter, motor endplate length, and percentage of motor endplates with nerve contact were examined to assess hIGF-1 trophic effects. Results: Compared with reinnervated untreated control samples, both early and delayed hIGF-1 transfer resulted in significant increase in muscle fiber diameter. Motor endplate length was significantly decreased and nerve/motor endplate contact was significantly increased following delayed gene transfer, but not after early treatment. Conclusion: We infer from results of the study that delayed hIGF-1 gene transfer delivered by a single intramuscular injection will enhance the process of muscle reinnervation. The clinical relevance of these findings supports the future application of gene therapy using nonviral vectors for management of laryngeal paralysis and other peripheral nerve injuries.

Original languageEnglish (US)
Pages (from-to)726-732
Number of pages7
JournalLaryngoscope
Volume114
Issue number4
DOIs
StatePublished - Apr 2004

Fingerprint

Laryngeal Muscles
Somatomedins
Motor Endplate
Genes
Vocal Cord Paralysis
Muscles
Recurrent Laryngeal Nerve Injuries
Peripheral Nerve Injuries
Intramuscular Injections
Reverse Transcriptase Polymerase Chain Reaction
Genetic Therapy
Actins
Appointments and Schedules
Plasmids
Prospective Studies
Polymerase Chain Reaction
Injections

Keywords

  • Gene therapy
  • Larynx
  • Muscle
  • Reinnervation

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Nakagawa, H., Shiotani, A., O'Malley, B. W., Coleman, M. E., & Flint, P. W. (2004). Timing of Human Insulin-Like Growth Factor-1 Gene Transfer in Reinnervating Laryngeal Muscle. Laryngoscope, 114(4), 726-732. https://doi.org/10.1097/00005537-200404000-00024

Timing of Human Insulin-Like Growth Factor-1 Gene Transfer in Reinnervating Laryngeal Muscle. / Nakagawa, Hideki; Shiotani, Akihiro; O'Malley, Bert W.; Coleman, Michael E.; Flint, Paul W.

In: Laryngoscope, Vol. 114, No. 4, 04.2004, p. 726-732.

Research output: Contribution to journalArticle

Nakagawa, H, Shiotani, A, O'Malley, BW, Coleman, ME & Flint, PW 2004, 'Timing of Human Insulin-Like Growth Factor-1 Gene Transfer in Reinnervating Laryngeal Muscle', Laryngoscope, vol. 114, no. 4, pp. 726-732. https://doi.org/10.1097/00005537-200404000-00024
Nakagawa, Hideki ; Shiotani, Akihiro ; O'Malley, Bert W. ; Coleman, Michael E. ; Flint, Paul W. / Timing of Human Insulin-Like Growth Factor-1 Gene Transfer in Reinnervating Laryngeal Muscle. In: Laryngoscope. 2004 ; Vol. 114, No. 4. pp. 726-732.
@article{9d8c080b6c404f46aba443f7771cbcdd,
title = "Timing of Human Insulin-Like Growth Factor-1 Gene Transfer in Reinnervating Laryngeal Muscle",
abstract = "Objectives/Hypothesis: The authors have designed a rat laryngeal paralysis model to study gene transfer strategies using a muscle-specific expression system to enhance local delivery of human insulin-like growth factor-1 (hIGF-1). In preliminary studies, a nonviral vector containing the α-actin promoter and human hIGF-1 sequence produced both neurotrophic and myotrophic effects 1 month after single injection of plasmid formulation into paralyzed rat thyroarytenoid muscle in vivo. Based on these findings, it is hypothesized that the effects of hIGF-1 will enhance the results of laryngeal muscle innervation procedures. The timing of gene delivery relative to nerve repair is likely to be important, to optimize the results. Study Design: Prospective analysis. Methods: The effects of nonviral gene transfer for the delivery of hIGF-1 were evaluated in rats treated immediately following recurrent laryngeal nerve transection and repair and in rats receiving a delayed treatment schedule, 30 days after nerve transection and repair. Gene transfer efficiency was determined using polymerase chain reaction and reverse transcriptase-polymerase chain reaction techniques. Muscle fiber diameter, motor endplate length, and percentage of motor endplates with nerve contact were examined to assess hIGF-1 trophic effects. Results: Compared with reinnervated untreated control samples, both early and delayed hIGF-1 transfer resulted in significant increase in muscle fiber diameter. Motor endplate length was significantly decreased and nerve/motor endplate contact was significantly increased following delayed gene transfer, but not after early treatment. Conclusion: We infer from results of the study that delayed hIGF-1 gene transfer delivered by a single intramuscular injection will enhance the process of muscle reinnervation. The clinical relevance of these findings supports the future application of gene therapy using nonviral vectors for management of laryngeal paralysis and other peripheral nerve injuries.",
keywords = "Gene therapy, Larynx, Muscle, Reinnervation",
author = "Hideki Nakagawa and Akihiro Shiotani and O'Malley, {Bert W.} and Coleman, {Michael E.} and Flint, {Paul W.}",
year = "2004",
month = "4",
doi = "10.1097/00005537-200404000-00024",
language = "English (US)",
volume = "114",
pages = "726--732",
journal = "Laryngoscope",
issn = "0023-852X",
publisher = "John Wiley and Sons Inc.",
number = "4",

}

TY - JOUR

T1 - Timing of Human Insulin-Like Growth Factor-1 Gene Transfer in Reinnervating Laryngeal Muscle

AU - Nakagawa, Hideki

AU - Shiotani, Akihiro

AU - O'Malley, Bert W.

AU - Coleman, Michael E.

AU - Flint, Paul W.

PY - 2004/4

Y1 - 2004/4

N2 - Objectives/Hypothesis: The authors have designed a rat laryngeal paralysis model to study gene transfer strategies using a muscle-specific expression system to enhance local delivery of human insulin-like growth factor-1 (hIGF-1). In preliminary studies, a nonviral vector containing the α-actin promoter and human hIGF-1 sequence produced both neurotrophic and myotrophic effects 1 month after single injection of plasmid formulation into paralyzed rat thyroarytenoid muscle in vivo. Based on these findings, it is hypothesized that the effects of hIGF-1 will enhance the results of laryngeal muscle innervation procedures. The timing of gene delivery relative to nerve repair is likely to be important, to optimize the results. Study Design: Prospective analysis. Methods: The effects of nonviral gene transfer for the delivery of hIGF-1 were evaluated in rats treated immediately following recurrent laryngeal nerve transection and repair and in rats receiving a delayed treatment schedule, 30 days after nerve transection and repair. Gene transfer efficiency was determined using polymerase chain reaction and reverse transcriptase-polymerase chain reaction techniques. Muscle fiber diameter, motor endplate length, and percentage of motor endplates with nerve contact were examined to assess hIGF-1 trophic effects. Results: Compared with reinnervated untreated control samples, both early and delayed hIGF-1 transfer resulted in significant increase in muscle fiber diameter. Motor endplate length was significantly decreased and nerve/motor endplate contact was significantly increased following delayed gene transfer, but not after early treatment. Conclusion: We infer from results of the study that delayed hIGF-1 gene transfer delivered by a single intramuscular injection will enhance the process of muscle reinnervation. The clinical relevance of these findings supports the future application of gene therapy using nonviral vectors for management of laryngeal paralysis and other peripheral nerve injuries.

AB - Objectives/Hypothesis: The authors have designed a rat laryngeal paralysis model to study gene transfer strategies using a muscle-specific expression system to enhance local delivery of human insulin-like growth factor-1 (hIGF-1). In preliminary studies, a nonviral vector containing the α-actin promoter and human hIGF-1 sequence produced both neurotrophic and myotrophic effects 1 month after single injection of plasmid formulation into paralyzed rat thyroarytenoid muscle in vivo. Based on these findings, it is hypothesized that the effects of hIGF-1 will enhance the results of laryngeal muscle innervation procedures. The timing of gene delivery relative to nerve repair is likely to be important, to optimize the results. Study Design: Prospective analysis. Methods: The effects of nonviral gene transfer for the delivery of hIGF-1 were evaluated in rats treated immediately following recurrent laryngeal nerve transection and repair and in rats receiving a delayed treatment schedule, 30 days after nerve transection and repair. Gene transfer efficiency was determined using polymerase chain reaction and reverse transcriptase-polymerase chain reaction techniques. Muscle fiber diameter, motor endplate length, and percentage of motor endplates with nerve contact were examined to assess hIGF-1 trophic effects. Results: Compared with reinnervated untreated control samples, both early and delayed hIGF-1 transfer resulted in significant increase in muscle fiber diameter. Motor endplate length was significantly decreased and nerve/motor endplate contact was significantly increased following delayed gene transfer, but not after early treatment. Conclusion: We infer from results of the study that delayed hIGF-1 gene transfer delivered by a single intramuscular injection will enhance the process of muscle reinnervation. The clinical relevance of these findings supports the future application of gene therapy using nonviral vectors for management of laryngeal paralysis and other peripheral nerve injuries.

KW - Gene therapy

KW - Larynx

KW - Muscle

KW - Reinnervation

UR - http://www.scopus.com/inward/record.url?scp=1842453330&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1842453330&partnerID=8YFLogxK

U2 - 10.1097/00005537-200404000-00024

DO - 10.1097/00005537-200404000-00024

M3 - Article

C2 - 15064631

AN - SCOPUS:1842453330

VL - 114

SP - 726

EP - 732

JO - Laryngoscope

JF - Laryngoscope

SN - 0023-852X

IS - 4

ER -